X4 Pharmaceuticals, Inc. buy B. Riley
Start price
31.08.23
/
50%
€1.19
Target price
31.08.24
-
Performance (%)
-28.95%
Price
16.05.24
€0.88
Summary
This prediction is currently active. The prediction for X4 Pharmaceuticals, Inc. disappoints with a performance of -28.95%. This prediction currently runs until 31.08.24. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
X4 Pharmaceuticals, Inc. | -9.852% | -9.852% |
iShares Core DAX® | -0.383% | 5.404% |
iShares Nasdaq 100 | 1.248% | 6.732% |
iShares Nikkei 225® | 0.525% | 1.840% |
iShares S&P 500 | 0.640% | 4.710% |
Comments by B__Riley for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "buy" rating re-affirmed by analysts at B. Riley.
Ratings data for XFOR provided by MarketBeat